Dr Margot Lehman MBBS FRANZCR GDP

From Cancer Guidelines Wiki

My pages


Pending critical appraisals

Clinical question Citation


What is the optimal management of Pancoast tumours? Solli P, Casiraghi M, Brambilla D, Maisonneuve P, Spaggiari L 2017 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Waseda R, Klikovits T, Hoda MA, Hoetzenecker K, Bertoglio P, Dieckmann K, et al 2017 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Jeannin G, Merle P, Janicot H, Thibonnier L, Kwiatkowski F, Naame A, et al 2015 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Xue Z, Wu F, Pierson KE, Mara KC, Yang P, Roden AC, et al 2017 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Buderi SI, Shackcloth M, Woolley S 2016 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Filis AK, Robinson LA, Vrionis FD 2016 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Ozmen O, Yilmaz U, Dadali Y, Tatci E, Gokcek A, Aydin E, et al 2015 Complete this critical appraisal


What is the optimal management of Pancoast tumours? Zairi F, Sunna T, Liberman M, Boubez G, Wang Z, Shedid D 2016 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Agolli L, Valeriani M, Bracci S, Nicosia L, DE Sanctis V, Enrici RM, et al 2015 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, et al 2017 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Ren XC, Wang QY, Zhang R, Chen XJ, Wang N, Liu YE, et al 2016 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Hansen O, Knap MM, Khalil A, Nyhus CH, McCulloch T, Holm B, et al 2017 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Zhai XJ, Cheng HR, Long HL, Mao WK, Cao L, Xiao BR, et al 2015 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Deutsch E, Le Péchoux C, Faivre L, Rivera S, Tao Y, Pignon JP, et al 2015 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Xu X, Ye X, Liu G, Zhang T 2015 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Hatton MQ, Hill R, Fenwick JD, Morgan SA, Wilson PC, Atherton PJ, et al 2015 Complete this critical appraisal


What is the optimal radiation dose and fractionation schedule for good performance status patients with inoperable stage III NSCLC undergoing curative therapy? Cagney DN, Thirion PG, Dunne MT, Fleming C, Fitzpatrick D, O'Shea CM, et al 2017 Complete this critical appraisal


Completed critical appraisals

More completed appraisals